ERBB2 and colorectal cancer: According to the diagnostic criteria for colorectal cancer, FISH analysis also revealed that HER2 amplification was acquired along with cetuximab resistance after cetuximab therapy (HER2 copy numbers: before therapy, 1.14 and after therapy, 2.78; Figure 2).